The etiology of osteosarcoma

Cancer Treatment and Research

Volumn 152, Issue , 2009, Pages 15-32

  Ottaviani, Giulia ^a   Jaffe, Norman ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; CELL PROTEIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DIMETHOATE; PROTEIN P53; PROTEIN RECQL4; RADIUM 224; RECQ HELICASE; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA PROTEIN 1; THORIUM DIOXIDE; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; BODY GROWTH; BODY HEIGHT; BONE DISEASE; BONE DYSPLASIA; BONE INFARCTION; BONE INJURY; BONE MALFORMATION; BONE PROSTHESIS; CANCER SURVIVAL; CATARACT; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHRONIC OSTEOMYELITIS; CLINICAL FEATURE; CONFERENCE PAPER; ENCHONDROMA; ENCHONDROMATOSIS; ETHNIC DIFFERENCE; EWING SARCOMA; FAMILIAL CANCER; FAMILY HISTORY; FIBROUS DYSPLASIA; GASTROINTESTINAL DISEASE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; HEREDITARY MULTIPLE EXOSTOSIS; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IONIZING RADIATION; KARYOTYPING; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; NONHUMAN; OSTEOCHONDROMA; OSTEOSARCOMA; OSTEOSYNTHESIS; PERINATAL PERIOD; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RASH; RETINOBLASTOMA; RISK FACTOR; ROTHMUND THOMSON SYNDROME; SCANTY HAIR; SEX DIFFERENCE; SHORT STATURE; SOLID TUMOR; TREATMENT RESPONSE; VIRUS CARCINOGENESIS; VIRUS INFECTION; BONE NEOPLASMS; GENETICS; NEOPLASMS, RADIATION-INDUCED;

ALKYLATING AGENTS; BONE NEOPLASMS; HUMANS; NEOPLASMS, RADIATION-INDUCED; OSTEOSARCOMA;

EID: 77953654549     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0284-9_2     Document Type: Conference Paper

References (86)

1. Gurney JG, Swensen AR, Bulterys M. Malignant bone tumors. In: Ries LA, Smith MAS, Gurney JG, et al., eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute; 1999. Available at: http://seer.cancer.gov/publications/ childhood/bone.pdf; Accessed August 2008.
2. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2001 Incidence and Mortality. Atlanta, GA: Centers for Disease Control and Prevention and National Cancer Institute; 2004.
3. Jaffe N. Malignant bone tumors in children: incidence and etiologic considerations. In: Jaffe N, ed. Solid Tumors in Childhood. Littleton, MA: PSG Publishing Co; 1979:1-10.
4. Miller RW, Boice JD Jr, Curtis RE. Bone cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press; 1996:971-983.
5. Dahlin DC, Unni KK, eds. Bone Tumors: General Aspects and Data on 8,542 Cases. 4th ed. Springfield, IL: Charles C. Thomas; 1986.
6. Hartford CM, Wodowski KS, Rao BN, et al. Osteosarcoma among children aged 5 years or younger: the St Jude Children's Research Hospital experience. J Pediatr Hematol Oncol. 2006;28:43-47.
7. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer. 2008;112:416-432.
8. Tjalma RA. Canine bone sarcoma: estimation of relative risk as a function of body size. J Natl Cancer Inst. 1966;3:1137-1150.
9. Mascarenhas L, Siegel S, Spector L, et al. Malignant bone tumors. In: Bleyer A, O'Leary M, Barr R, et al., eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000 (NIH Pub. No. 06-5767). Bethesda, MD: National Cancer Institute; 2006:97-110. Available at: http://seer.cancer.gov/ publications/aya/8-bone.pdf; Accessed January 2009.
10. Price CH. Primary bone-forming tumours and their relationship to skeletal growth. J Bone Joint Surg Br. 1958;36:1137-1150.
11. Buckley JD, Pendergrass TW, Buckley CM, et al. Epidemiology of osteosarcoma and Ewing's sarcoma in childhood: a study of 305 cases by the Children's Cancer Group. Cancer. 1998;83: 1440-1448.
12. Cotterill SJ, Wright CM, Pearce MS, et al. Stature of young people with malignant bone tumors. Pediatr Blood Cancer. 2004;42:59-63.
13. Longhi A, Pasini A, Cicognani A, et al. Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol. 2005;27:314-318.
14. Troisi R, Masters MN, Joshipura K, et al. Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer. 2006;95:1603-1607.
15. Operskalski EA, Preston-Martin S, Henderson BE, et al. A case-control study of osteosarcoma in young persons. Am J Epidemiol. 1987;126:118-126.
16. dos Santos Aguiar S, de Jesus Girotto Zambaldi L, dos Santos AM, et al. Comparative genomic hybridization analysis of abnormalities in chromosome 21 in childhood osteosarcoma. Cancer Genet Cytogenet. 2007;175:35-40.
17. Ottaviani G, Jaffe N. Clinical and pathological study of two siblings with osteosarcoma. Med Pediatr Oncol. 2002;38:62-64.
18. Harmon TP, Morton KS. Osteogenic sarcoma in four siblings. J Bone Joint Surg Br. 1966;48:493-498.
19. Robbins R. Familial osteosarcoma. Fifth reported occurrence. JAMA. 1967;202:1055.
20. Epstein LI, Bixler D, Bennett JE. An incident of familial cancer, including 3 cases of ostogenic sarcoma. Cancer. 1970;25:889-891.
21. Swaney JJ. Familial osteogenic sarcoma. Clin Orthop. 1973;97:64-68.
22. Miller CW, McLaughlin RE. Osteosarcoma in siblings. Report of two cases. J Bone Joint Surg Am. 1977;59:261-262.
23. Mulvihill JJ, Gralnick HR, Whang-Peng J, et al. Multiple childhood osteosarcomas in an American Indian family with erythroid macrocytosis and skeletal anomalies. Cancer. 1977;40:3115-3122.
24. Colyer RA. Osteogenic sarcoma in siblings. Johns Hopkins Med J. 1979;145:131-135.
25. Hillmann A, Ozaki T, Winkelmann W. Familial occurrence of osteosarcoma. A case report and review of the literature. J Cancer Res Clin Oncol. 2000;126:497-502.
26. Chin KR, Mankin HJ, Gebhardt MC. Primary osteosarcoma of the distal femur in two consecutive brothers. Clin Orthop Relat Res. 2001;382:191-196.
27. Norrdin RW, Powers BE, Torgersen JL, et al. Characterization of osteosarcoma cells from two sibling large-breed dogs. Am J Vet Res. 1989;50:1971-1975.
28. Glass AG, Fraumeni JF Jr. Epidemiology of bone cancer in children. J Natl Cancer Inst. 1970;44:187-199.
29. Longhi A, Benassi MS, Molendini L, et al. Osteosarcoma in blood relatives. Oncol Rep. 2001;8:131-136.
30. Ji J, Hemminki K. Familial risk for histology-specific bone cancers: an updated study in Sweden. Eur J Cancer. 2006;42:2343-2349.
31. Nishida J, Abe M, Shiraishi H, et al. Familial occurrence of telangiectatic osteosarcoma: cousin cases. J Pediatr Orthop. 1994;14:119-122.
32. Hansen MF. Genetic and molecular aspects of osteosarcoma. J Musculoskelet Neuronal Interact. 2002;2:554-560.
33. Patiño-García A, Piñeiro ES, Díez MZ, et al. Genetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomas. J Pediatr Hematol Oncol. 2003;25:362-367.
34. Levesque AA, Eastman A. p53-based cancer therapies: is defective p53 the Achilles heel of the tumor? Carcinogenesis. 2007;28:13-20.
35. Kaseta MK, Khaldi L, Gomatos IP, et al. Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma. J Surg Oncol. 2008;97:259-266.
36. Gebhardt MC. Molecular biology of sarcomas. Orthop Clin North Am. 1996;27:421-429.
37. Jensen RD, Miller RW. Retinoblastoma: epidemiologic characteristics. N Engl J Med. 1971;285:307-311.
38. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986;53:661-671.
39. Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Soft Tissue and Bone. Lyon: IARC Press; 2002.
40. Le Vu B, de Vathaire F, Shamsaldin A, et al. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer. 1998;77:370-377.
41. McIntyre JF, Smith-Sorensen B, Friend SH, et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol. 1994;12:925-930.
42. Li FP, Fraumeni JF Jr. Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Intern Med. 1969;71:747-752.
43. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res. 1988;48:5358-5362.
44. Plon SE, Malkin D. Childhood cancer and heredity. In: Pizzo PA, Poplack DG, eds. Principles and Practices of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006:14-37.
45. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Cancer. 1990;250:1233-1238.
46. Birch JM, Hartley AL, Tricker KJ, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994;54:1298-1304.
47. Frebourg T, Barbier N, Yan Y, et al. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet. 1995;56:608-615.
48. Kitao S, Shimamoto A, Goto M, et al. Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nat Genet. 1999;22:82-84.
49. Sim FH, Devries EM, Miser JS, et al. Case report 760: Osteoblastic osteosarcoma (grade 4) with Rothmund-Thomson syndrome. Skeletal Radiol. 1992;21:543-545.
50. Wang LL, Levy ML, Lewis RA, et al. Clinical manifestations in a cohort of 41 Rothmund- Thomson syndrome patients. Am J Med Genet. 2001;102:11-17.
51. Hicks MJ, Roth JR, Kozinetz CA, et al. Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome. J Clin Oncol. 2007;25:370-375.
52. Beghini A, Larizza L. Rothmund-Thomson syndrome (RTS). Atlas Genet Cytogenet Oncol Haematol. Milan, Italy; 2001. http://atlasgeneticsoncology.org/ Kprones/RothmundID10021. html; Accessed January 2009.
53. German J. Bloom's syndrome: XX - The first 100 cancers. Cancer Genet Cytogenet. 1997;93:100-106.
54. Goto M, Miller RW, Ishikawa Y, et al. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev. 1996;5:239-246.
55. Ishikawa Y, Miller RW, Machinami R, et al. Atypical osteosarcomas in Werner Syndrome (adult progeria). Jpn J Cancer Res. 2000;91:1345-1349.
56. Marcove RC, Miké V, Hajeck JV, et al. Osteogenic sarcoma under the age of twenty one. A review of one hundred and forty-five operative cases. J Bone Joint Surg Am. 1970;52:411-423.
57. McKenna RJ, Schwinn CP, Soonh KY, et al. Sarcomata of osteogenic series (osteosarcoma, fibrosarcoma, chondrosarcoma, parosteal osteosarcoma, and sarcomata arising in abnormal bone): an analysis of 552 cases. J Bone Joint Surg Am. 1966;48-A:1-26.
58. Rockwell MA, Enneking WF. Osteosarcoma developing in solitary enchondroma of the tibia. J Bone Joint Surg Am. 1971;53:341-344.
59. Huvos AG, Higinbotham NL, Miller TR. Bone sarcomas arising in fibrous dysplasia. J Bone Joint Surg Am. 1972;54:1047-1056.
60. Braddock GT, Hadlow VD. Osteosarcoma in enchondromatosis (Ollier's disease). Report of a case. J Bone Joint Surg Br. 1966;48:145-149.
61. Johnston RM, Miles JS. Sarcomas arising from chronic osteomyelitic sinuses. A report of two cases. J Bone Joint Surg Am. 1973;55:162-168.
62. Sim FH, Cupps RE, Dahlin DC, et al. Postradiation sarcoma of bone. J Bone Joint Surg Am. 1972;54:1479-1489.
63. Huvos A. Bone Tumors: Diagnosis, Treatment, and Prognosis. 2nd ed. Philadelphia, PA: Saunders; 1991.
64. Inskip PD, Ries LAG, Cohen RJ, et al. New malignancies following childhood cancer. In: Curtis RE, Freedman DM, Ron E, et al., eds. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000 (NIH Publ. No. 05-5302). Bethesda, MD: National Cancer Institute; 2006. Available at: http://seer.cancer.gov/publications/mpmono/Ch18- Childhood.pdf; Accessed August 2008.
65. Kalra S, Grimer RJ, Spooner D, et al. Radiation-induced sarcomas of bone: factors that affect outcome. J Bone Joint Surg Br. 2007;89:808-813.
66. Spiess H, Mays CW. Bone cancers induced by 224 Ra (Th X) in children and adults. Health Phys. 1970;19:713-729.
67. Shaheen M, Deheshi BM, Riad S, et al. Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma. Clin Orthop Relat Res. 2006;450:76-81.
68. Loutit JF. Malignancy from radium. Br J Cancer. 1970;24:195-207.
69. Aub JC, Evans RD, Hempelmann LH, et al. The late effects of internally-deposited radioactive materials in man. Medicine. 1952;31:221-329.
70. Harrist TJ, Schiller AL, Trelstad RL, et al. Thorotrast-associated sarcoma of bone: a case report and review of the literature. Cancer. 1979;44:2049-2058.
71. Yamamoto T, Wakabayashi T. Bone tumors among the atomic bomb survivors of Hiroshima and Nagasaki. Acta Pathol Jpn. 1969;19:201-212.
72. Shigematsu I. Health effects of atomic bomb radiation. Rinsho Byori. 1994;42:313-319.
73. Harvey RT, Donald PJ, Weinstein GS. Osteogenic sarcoma of the maxillary alveolus occurring five years following the Chernobyl nuclear accident. Am J Otolaryngol. 1996;17:210-214.
74. Finkelstein MM, Kreiger N. Radium in drinking water and risk of bone cancer in Ontario youths: a second study and combined analysis. Occup Environ Med. 1996;53:305-311.
75. Newton WA Jr, Meadows AT, Shimada H, et al. Bone sarcomas as second malignant neoplasms following childhood cancer. Cancer. 1991;67:193-201.
76. Henderson TO, Whitton J, Stovall M, et al. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2007;99:300-308.
77. Zilioli E, Ottaviani C. Osteosarcoma: concetti attuali di patologia e nuove prospettive terapeutiche. Nota I: aspetti bioimmulogici della neoplasia. Chir Ital. 1978;30:953-961.
78. Zilioli E, Ottaviani C. Osteosarcoma: concetti attuali di patologia e nuove prospettive terapeutiche. Nota II: criteri prognostici e terapia. Chir Ital. 1978;30:975-991.
79. Finkel MP, Jinkins PB, Tolle J, et al. Serial radiography of virus-induced osteosarcomas in mice. Radiology. 1966;87:333-339.
80. Finkel MP, Biskis BO, Farrell C. Pathogenic effects of extracts of human osteosarcomas in hamsters and mice. Arch Pathol. 1967;84:425-428.
81. Finkel MP, Biskis BO, Farrell C. Osteosarcomas appearing in Syrian hamsters after treatment with extracts of human osteosarcomas. Proc Natl Acad Sci USA. 1968;60:1223-1230.
82. Finkel MP, Biskis BO, Farrell C. Nonmalignant and malignant changes in hamsters inoculated with extracts of human osteosarcomas. Radiology. 1969;92:1546-1552.
83. Reilly CA Jr, Pritchard DJ, Biskis BO, et al. Immunologic evidence suggesting a viral etiology of human osteosarcoma. Cancer. 1972;30:603-609.
84. Finkel MP, Reilly CA Jr, Biskis BO. Pathogenesis of radiation and virus-induced bone tumors. Recent Results Cancer Res. 1976;54:92-103.
85. Eilber FR, Morton DL. Sarcoma-specific antigens: detection by complement fixation with serum from sarcoma patients. J Natl Cancer Inst. 1970;44:651-656.
86. Shah KV. SV40 and human cancer: a review of recent data. Int J Cancer. 2007;120:215-223.